D001 Derm Tank
DESCRIPTION
In this Derm Tank session presenters will pitch their dermatology-related ideas with commercial potential including new techniques, devices, products or instruments to a panel of esteemed judges. The presentations will be scored for innovation and commercial viability. The highest-rated presenter will receive a "seed" money honorarium.
Come join us to see our 3 finalists present the following innovations:
1. Dr. Justin Marson: New Dimensions in Dermatology: Light Detection and Ranging (LiDAR) as a tool to democratize three-dimensional imaging
2. Dr. Kamryn Abraskin: EpiDetect
3. Dr. Eran Gwillim: Jerry - the evidence-based AI-powered platform
This session is not certified for AMA PRA Category 1 CME Credit.
LEARNING OBJECTIVES
Apply novel and innovative technology to everyday dermatology practice.
Introduce products for patients that improve their dermatology care.
Determine the best commercially viable novel efforts that are likely to make it to market.
SCHEDULE
11:00 PM
AAD Innovation Shark Tank 2024
SPEAKERS
Kamryn Abraskin, MM
Carle Illinois College of Medicine
Brett M. Coldiron, MD, FAAD
Eran Gwillim, MD
Elli & Co. San Diego, CA.; Scripps Clinic, San Diego, CA. PGY5 Fellow, Micrographic Surgery and Dermatologic Oncology; Voluntary Associate Professor, Department of Dermatology and Cutaneous Surgery University of Miami Miller School of Medicine, Miami, FL.
Mark D. Kaufmann, MD, FAAD
Ivy Lee, MD, FAAD
Justin W Marson, MD
Department of Dermatology, SUNY Downstate Health Sciences University, Brooklyn, NY
Maryam Safaee, MD, FAAD
Daniel M. Siegel, MS, MD, FAAD
Downstate University Medical Center
Cory Simpson, MD, PhD, FAAD
Department of Dermatology, University of Washington
SPEAKER DISCLOSURES
Kamryn Abraskin, MM
No financial relationships exist with ineligible companies.
Brett M. Coldiron, MD, FAAD
No financial relationships exist with ineligible companies.
Eran Gwillim, MD
Apple Inc. – Stockholder Public Company(Stock); Dermsquared – Other(Other Financial Benefit); Doximity Inc. – Stockholder Public Company(Stock); Elli & Co. – Founder(No Compensation Received); Google – Stockholder Public Company(Stock);
Mark D. Kaufmann, MD, FAAD
Almirall – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Avita Medical – Consultant (1099 relationship)(Fees); Biofrontera – Consultant (1099 relationship)(Fees); Dermsquared – Other(Fees); DermTech Inc. – Consultant (1099 relationship)(Fees); Feldan Therapeutics – Consultant (1099 relationship)(Fees); Incyte – Consultant (1099 relationship)(Fees); Modernizing Medicine – Consultant(Stock); MoleSafe, Inc. – Other(Stock); Novan – Consultant (1099 relationship)(Fees); Novartis – Consultant (1099 relationship)(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Pelthos Therapeutics – Consultant (1099 relationship)(Fees); Rise Healthcare Tech, Inc. – Advisory Board(Stock Options); Rivera Consulting – Consultant (1099 relationship)(Fees); ROM Technologies Inc. – Consultant (1099 relationship)(Stock); Sanofi/Regeneron – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); UCB Pharma – Consultant (1099 relationship)(Fees); Verrica Pharmaceuticals Inc – Consultant (1099 relationship)(Fees);
Ivy Lee, MD, FAAD
DIrect Dermatology – Stockholder(Stock Options);
Justin W Marson, MD
American Academy of Dermatology – Other(Grants/Research Funding); Berman Medical – Other(No Compensation Received); Blair & Jack – Consultant(Fees); Castle Biosciences, Inc – Advisory Board(Honoraria); CeraVe/Valeante – Consultant(Honoraria); Doximity Inc. – Advisory Board(Stock); Ferndale Laboratories, Inc. – Advisory Board(Honoraria); La Roche-Posay – Other(Grants/Research Funding); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Honoraria);
Maryam Safaee, MD, FAAD
No financial relationships exist with ineligible companies.
Daniel M. Siegel, MS, MD, FAAD
Avita – Advisory Board(Honoraria), Consultant(Honoraria); Biofrontera AG – Stockholder(Stock); Caliber Imaging and Diagnostics Inc. – Board of Directors(Stock); Cara Therapeutics – Advisory Board(Honoraria); DermaSensor Inc – Consultant(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Feldan Therapeutics – Consultant(Fees); Greenway Therapeutix – Advisory Board(No Compensation Received), Stockholder(Stock); Lazarus Enterprises Inc. – Consultant(Stock Options); Logical Images – Consultant(Stock Options); Medforce Technologies, Inc. – Consultant(Fees); Modernizing Medicine – Advisory Board(Stock); MycoMedica Life Sciences – Advisory Board(No Compensation Received); Novascan – Stockholder(No Compensation Received); Omnilux – Advisory Board(Equipment); Or-Genix, Therapeutics – Board of Directors(Stock Options), Stockholder(No Compensation Received); Plasmend – Stockholder(No Compensation Received); Pulse Biosciences – Consultant(Fees); RaMedical – Stockholder(No Compensation Received); RBC Consultants – Consultant (1099 relationship)(Honoraria); Regeneron – Investigator(Grants/Research Funding), Speaker(Honoraria); Seaspire Skincare – Consultant(Stock Options); SkinVision – Advisory Board(Stock Options); SPC Dermatology – Employee(Salary); Strata Skin Sciences – Consultant(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); Tetros Group – Advisory Board(No Compensation Received), Stockholder(No Compensation Received); Verrica Pharmaceuticals Inc – Consultant(Fees);
Cory Simpson, MD, PhD, FAAD
argenx – Advisory Board(Fees); LEO Foundation – Investigator(Grants/Research Funding); Mitsubishi Tanabe Pharma Development America – Advisory Board(Fees); United Health Care – Employee(Salary), Employee(Stock Options);